Contributions
1,850 recent contributions in Hansard
HANSARDCovid-19 UpdateI thank both noble Baronesses for their questions and the important points they made. It is important that we are clear about many of the issues that they have brought up. Let us…10 Nov 2021HANSARDCovid-19 UpdateThere clearly are concerns. These were expressed in the stakeholder engagement that occurred with both the social care sector and other sectors that will need to bring this in…10 Nov 2021HANSARDGametes and Embryos: Storage LimitThe noble Baroness raises a very important point about same-sex couples’ access to insemination services. In England, details of the local fertility services are determined by the…09 Nov 2021HANSARDDavid Fuller CaseMy Lords, this is one of the most difficult issues that we have had to address and discuss in my short career at the Dispatch Box. It is one of those crimes that are beyond…09 Nov 2021HANSARDDavid Fuller CaseI am afraid I am not able to answer the noble Lord’s question directly, because clearly there are some legal issues around it. I am sure he will understand if I try to find an…09 Nov 2021HANSARDDavid Fuller CaseI thank the noble Lord for that suggestion. As we are all aware, there is a wide range of experience across this House, and it is important that we draw on that when it comes to…09 Nov 2021HANSARDDavid Fuller CaseI thank my noble friend for that suggestion. In conversation today with my officials, as I was preparing for the response to this Statement, the issue of CCTV did come up. At the…09 Nov 2021HANSARDPublic Health England (Dissolution) (Consequential Amendments) Regulations 2021My Lords, I thank the noble Baroness for securing this important debate on secondary legislation in relation to the Government’s public health reforms, and also for this…09 Nov 2021HANSARDPublic Health England (Dissolution) (Consequential Amendments) Regulations 2021Maybe it is because I speak rather quickly, but in my remarks just now I talked about the difference between the negative and affirmative procedures, and the affirmative procedure…09 Nov 2021HANSARDGametes and Embryos: Storage LimitI thank the noble Baroness for that very kind offer, but we have already stated that it is the Government’s intention that no one misses out on the opportunity to extend the…09 Nov 2021HANSARDGametes and Embryos: Storage LimitI thank my noble friend for his work on the subject when he was the responsible Minister to help change the policy so that all people, regardless of medical need, may benefit from…09 Nov 2021HANSARDGametes and Embryos: Storage LimitI thank the noble Baroness for raising this very important issue, because not everyone is aware of the biological facts around fertility, particularly the decline of fertility…09 Nov 2021HANSARDGametes and Embryos: Storage LimitThe Government are still considering the responses from the technical consultation in terms of extension of storage, but as I said previously, and I hope the noble Baroness will…09 Nov 2021HANSARDGametes and Embryos: Storage LimitThe department has been working with the regulator, the Human Fertilisation and Embryology Authority, to ensure that it gets a chance to input into how the new scheme is…09 Nov 2021HANSARDDavid Fuller CaseAs my noble friend anticipated, I am afraid I do not have a detailed answer. I am sorry; I wish I did have the answers, but I will write to him.09 Nov 2021HANSARDDavid Fuller CaseI thank the noble Lord for that suggestion. As far as I understand, the inquiry will be as wide ranging as it can be and wants to include input from as many people and…09 Nov 2021HANSARDNHS: Fracture Liaison ServicesI thank my noble friend for raising this issue and for the work he has done as part of the all-party group. I look forward to reading the report it is writing on this important…08 Nov 2021HANSARDCancer Drugs: Licensing and ApprovalThe noble Baroness raises an important point, especially given that health is devolved to the devolved Administrations. As much as possible, we work England-wide, but we also…08 Nov 2021HANSARDCancer Drugs: Licensing and ApprovalBoth NICE and MHRA are aware of the concerns, particularly regarding the delay between approval and licensing. That is why they are having conversations with NHS England and NHS…08 Nov 2021HANSARDCancer Drugs: Licensing and ApprovalI thank my noble friend for his question. The focus was on fighting Covid and making sure that people were vaccinated as quickly as possible. As noble Lords know, economics is…08 Nov 2021